Evidence map›Paper›PMID 30837227›Full record

ArticleBiology open2019

The 1ALCTL and 1BLCTL isoforms of Arg/Abl2 induce fibroblast activation and extra cellular matrix remodelling differently.

Barbara Torsello, Sofia De Marco, Silvia Bombelli, Elisa Chisci, Valeria Cassina, Roberta Corti, Davide Bernasconi, Roberto Giovannoni, Cristina Bianchi, Roberto A Perego

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Biology open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Barbara TorselloSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy roberto.perego@unimib.it barbara.torsello@unimib.it.
Sofia De MarcoSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Silvia BombelliSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Elisa ChisciSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.ORCID http://orcid.org/0000-0002-4758-4803
Valeria CassinaSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Roberta CortiSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Davide BernasconiSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Roberto GiovannoniSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Cristina BianchiSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Roberto A PeregoSchool of Medicine & Surgery, University of Milano-Bicocca, 20900 Monza, Italy roberto.perego@unimib.it barbara.torsello@unimib.it.ORCID http://orcid.org/0000-0003-3053-3476
University of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fibrotic tissue and the stroma adjacent to cancer cells are characterised by the presence of activated fibroblasts (myofibroblasts) which play a role in creating a supportive tissue characterised by abundant extracellular matrix (ECM) secretion. The myofibroblasts remodel this tissue through secreted molecules and modulation of their cytoskeleton and specialized contractile structures. The non-receptor protein tyrosine kinase Arg (also called Abl2) has the unique ability to bind directly to the actin cytoskeleton, transducing diverse extracellular signals into cytoskeletal rearrangements. In this study we analysed the 1ALCTL and 1BLCTL Arg isoforms in Arg

Indexed as

Abl2ArgExtra cellular matrixFibroblastNon-receptor tyrosine kinaseStroma remodelling

Identifiers

PMID30837227
PMCPMC6451347
OpenAlexW2919347615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.